- $89.39bn
- $93.28bn
- $403.43bn
Mckesson Corp reports results for the quarter ended December 31 - Earnings Summary
Brief: McKesson Q3 Adjusted EPS USD 8.03 Vs. IBES Estimate USD 7.99
What to Watch in the Day Ahead - Wednesday, February 5
Brief: McKesson Advances Specialty Leadership; Signs Agreement to Acquire Controlling Interest in PRISM Vision Holdings, LLC
Cardinal Health may raise prices to offset potential tariffs (updated)
Cardinal Health lifts 2025 profit forecast on specialty drugs demand
West Virginia top court urged to revive landmark opioid case against distributors
U.S. STOCKS ON THE MOVE-BlackRock, WEX, Big banks
U.S. RESEARCH ROUNDUP- Fair Isaac, Mastercard, McKesson
Newscasts - Healthcare stocks 'a good place to be,' portfolio manager says
Press Digest: Canada - Jan 2
Drug distributors end 2024 on high note
Live Markets: Drug distributors' M&A race likely at its peak
Baltimore wins $266 million in opioid case against distributors
Mckesson Corp reports results for the quarter ended in September 30 - Earnings Summary
McKesson raises annual profit forecast on strength in its U.S. pharma segment
Brief: McKesson Q2 Adjusted EPS USD 7.07 Vs. IBES Estimate USD 6.88
What to Watch in the Day Ahead - Wednesday, November 6
Cardinal Health lifts annual profit outlook on strength in specialty medicines unit (updated)